Umeclidinium Bromide and Vilanterol Trifenatate Powder for Inhalation(Tianjin Pharmaceutical Peace (Tianjin) Pharma)

乌美溴铵维兰特罗吸入粉雾剂（津药和平（天津）制药）

Report date: 2025/08/28 16:31:32

Base Information

Drug NameUmeclidinium Bromide and Vilanterol Trifenatate Powder for Inhalation(Tianjin Pharmaceutical Peace (Tianjin) Pharma)
Drug Alias NameVilanterol Trifenatate and Umeclidinium Bromide芜地溴铵/Vilanterol TrifenatateVilanterol Trifenatate/Umeclidinium Bromide乌美溴铵/三苯乙酸维兰特罗Umeclidinium Bromide and Vilanterol Trifenatate +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M1 antagonistsBeta-2 adrenergic receptor agonistsMuscarinic acetylcholine receptor M4 antagonists +[6] 
TargetsBeta-2 adrenergic receptorMuscarinic acetylcholine receptor M2Muscarinic acetylcholine receptor M1 +[6] 
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTianjin Pharmaceutical Peace (Tianjin) Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Pharmaceutical Peace (Tianjin) Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG